Mark Medical Expands with Hermes-Pharma Acquisition

Deal News | Mar 21, 2025 | CEE Legal Matters

Mark Medical Expands with Hermes-Pharma Acquisition

Italian MedTech company Mark Medical, part of the SVAS Biosana Group, has acquired Hermes-Pharma, a MedTech company based in Belgrade, Serbia. Hermes-Pharma specializes in the wholesale distribution of medical devices and holds several marketing authorizations for products from major companies like Abbott Vascular, Johnson & Johnson, and Aidian. NKO Partners provided legal advice to Mark Medical, with a team consisting of Partners Djordje Nikolic and Branko Jankovic, and Associate Valerija Mandic. On the seller's side, Joksovic, Stojanovic & Partners offered legal counsel, with a team led by Senior Partners Petar Stojanovic and Dragan Psodorov, with support from Partner Goran Vucic and Associate Danilo Vukcevic. This acquisition represents a strategic expansion for Mark Medical in the MedTech sector.

Sectors

  • Medical Technology (MedTech)
  • Legal Advisory

Geography

  • Italy – Italy is home to Mark Medical, the acquiring company and a member of SVAS Biosana Group.
  • Serbia – Serbia is where Hermes-Pharma, the target company of the acquisition, is based.

Industry

  • Medical Technology (MedTech) – Both Mark Medical and Hermes-Pharma are identified as MedTech companies, focusing on the development and distribution of medical devices and technologies.
  • Legal Advisory – Legal firms NKO Partners and Joksovic, Stojanovic & Partners played advisory roles in the acquisition process.

Financials

    Participants

    NameRoleTypeDescription
    Mark MedicalAcquirerCompanyAn Italian MedTech firm and part of the SVAS Biosana Group.
    Hermes-PharmaTargetCompanyA Belgrade-based MedTech company known for the distribution of medical devices.
    NKO PartnersLegal Advisor to AcquirerCompanyProvided legal services to Mark Medical in the acquisition.
    Joksovic, Stojanovic & PartnersLegal Advisor to SellersCompanyProvided legal services to the sellers of Hermes-Pharma.